From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Charting, Price Performance, News & Related Contracts.

A small, but positive, randomized double-blind trial of baricitinib for PMR is the first in patients with the condition to ...

The plan, which rezones parts of the Manhattan neighborhood, aims to address the city’s housing shortage and the area’s ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

LilySilk opened its first-ever store in New York City on Friday. The 1,600-square-foot space, located at 654 Hudson St., in ...

Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...

As the J.P. Morgan Healthcare Conference enters its second day, we're tracking presentations from GSK, Novartis, Sanofi, Eli ...

The S&P 500 edged higher while the Nasdaq dipped after a volatile session on Tuesday as investors gauged inflation data and ...

Notably, the conference appears to have beefed up security around the main venue – the Westin St. Francis Hotel – this year ...